Clinical Trials Browser

Phase 3 × Active not recruiting × nimotuzumab × Clear all

NCT04456322 2025-05-14

Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma

Phase 3 Active not recruiting

Nasopharyngeal Carcinoma